The Great Biomarker Boom: Are We Overdiagnosing Risk or Finally Personalizing Medicine?

The Great Biomarker Boom: Are We Overdiagnosing Risk or Finally Personalizing Medicine? Review Abstract The rapid expansion of biomarker discovery and clinical application has created both unprecedented opportunities and substantial challenges in modern medicine. This analysis examines whether the current biomarker boom represents genuine progress

Anastomotic Leak Prediction: Biomarkers + AI vs Surgeon Judgment

Anastomotic Leak Prediction: Biomarkers + AI vs Surgeon Judgment   Key Takeaways Anastomotic leak prediction is evolving rapidly, with three distinct approaches showing different strengths and implementation timelines for surgical practice. AI models achieve 99.6% accuracy but face practical barriers. Biomarker protocols offer negative predictive

ALS News: Breakthrough Drug Shows Promising Results in Clinical Trials

ALS News: Breakthrough Drug Shows Promising Results in Clinical Trials   Introduction Recent ALS news reveals a groundbreaking personalized drug therapy that has demonstrated remarkable efficacy in slowing ALS progression. In April 2024, a patient received the first-ever antisense oligonucleotide (ASO) treatment targeting CHCHD10 mutations in

The Great Biomarker Boom: Are We Overdiagnosing Risk or Finally Personalizing Medicine?